세계의 산업 미생물학 시장 보고서 : 제품, 시험 유형, 최종 이용 산업, 지역별(2024-2032년)

The global industrial microbiology market size reached US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

Industrial microbiology or microbial biotechnology refers to the process of manipulating microorganisms for the benefit of the environment, society, and industries. These microorganisms, which are used to produce large-scale industrial products, include naturally occurring organisms, laboratory selected mutants, and genetically modified organisms (GMO). As industrial microbiology relies on renewable resources, it assists in replacing fossil fuels, non-biodegradable plastics, and highly polluting chemical processes with biocompatible alternatives. Presently, it finds extensive application in the manufacturing of alcohols and acetone across the globe.

Industrial Microbiology Market Trends:

The flourishing pharmaceutical industry represents one of the key factors strengthening the growth of the market. Industrial microbiology assists in the development of antibiotics, vaccines, and steroids. It also aids in maintaining the overall quality and preventing microbial contamination of drugs, injectables, eye drops, nasal solutions, and inhalation products. This, in confluence with the rising demand for antibiotics, is contributing to the market growth. Additionally, depleting oil resources and increasing energy demands are catalyzing the need for cost-effective and eco-friendly oil recovery technologies. Apart from this, as industrial microbiology does not require vast energy inputs and is not impacted by crude oil prices, it finds a wide array of applications in the oil and gas industry across the globe. Moreover, it is increasingly being employed in the food and beverage (F&B) industry for producing fermented food products and the conversion of industrial food wastes into value-added products. This, coupled with the technological advancements to improve productivity, enhance organoleptic characteristics, and attribute new nutritional functions to certain foods, is creating a favorable market outlook. The market is also propelled by the expanding applications of microbiology in the cosmetics and personal care industry worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global industrial microbiology market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, test type and end use industry.

Breakup by Product:

Equipment and Systems

Filtration Pumps and Systems

Microbial Detection Systems

Air Monitoring Systems

Automated Equipment

Incubators and Culture Apparatus

Others

Reaction Consumables

Media

Simple Media

Complex Media

Defined Media

Specialty Media

Reagents and Strains

Others

Laboratory Supplies

Bags and Bottles

Loop and Needles

Petri Dishes, Racks, Seals, Plates and Holders

Filtration Disc and Membranes

Others

Breakup by Test Type:

Sterility Testing

Microbial Limits Testing

Bio-burden Testing

Water and Environmental Testing

Breakup by End Use Industry:

Food and Beverages

Pharmaceutical Biotechnology

Agricultural

Environmental

Cosmetic and Personal Care

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corporation, Eppendorf AG, QIAGEN, Sartorius AG, Merck KGaA and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

• How has the global industrial microbiology market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global industrial microbiology market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the test type?
• What is the breakup of the market based on the end use industry?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global industrial microbiology market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Industrial Microbiology Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Equipment and Systems
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Filtration Pumps and Systems
    • 6.1.2.2 Microbial Detection Systems
    • 6.1.2.3 Air Monitoring Systems
    • 6.1.2.4 Automated Equipment
    • 6.1.2.5 Incubators and Culture Apparatus
    • 6.1.2.6 Others
  • 6.1.3 Market Forecast
• 6.2 Reaction Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Media
    • 6.2.2.2 Simple Media
    • 6.2.2.3 Complex Media
    • 6.2.2.4 Defined Media
    • 6.2.2.5 Specialty Media
    • 6.2.2.6 Reagents and Strains
  • 6.2.3 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Laboratory Supplies
    • 6.3.2.2 Bags and Bottles
    • 6.3.2.3 Loop and Needles
    • 6.3.2.4 Petri Dishes, Racks, Seals, Plates and Holders
    • 6.3.2.5 Filtration Disc and Membranes
    • 6.3.2.6 Others
  • 6.3.3 Market Forecast

7 Market Breakup by Test Type

• 7.1 Sterility Testing
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Microbial Limits Testing
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Bio-burden Testing
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Water and Environmental Testing
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End Use Industry

• 8.1 Food and Beverages
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceutical Biotechnology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Agricultural
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Environmental
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Cosmetic and Personal Care
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 bioMerieux SA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Bio-Rad Laboratories Inc
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Danaher Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Eppendorf AG
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 QIAGEN
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Sartorius AG
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Merck KGaA
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Thermo Fisher Scientific Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis